Publications & Events

Patent Litigation Articles

Speaking Engagements

  • "Life Technologies Corporation v. Promega," American University Washington College of Law's SCOTUS Series (December 6, 2016)

  • “Spotlight on the Judiciary: Lessons Learned for Biosimilars Litigation,” American Conference Institute’s 7th Annual Summit on Biosimilars (June 13, 2016)

  • "Pharmaceutical Patent Invalidity Challenge Score Card: District Courts v. the PTAB," ACI Paragraph IV Disputes Conference (April 25, 2016)

  • "Unprotected Discoveries: Patent Eligibility of New Applications of Previously-Unknown Natural Phenomena," 32nd Annual Joint Patent Practice Continuing Legal Education Seminar (April 21, 2016)

  • “Biosimilars Are Here. Now What?,” The Pharmaceutical Strategy Conference (September 30, 2015)

  • Inter Partes Review (IPR) Proceedings for Biotech and Pharmaceutical Patents: Key Strategies for U.S. Patent Owners,” Association of Corporate Counsel Webcast (June 17, 2015)

  • “Following the Rules of the BPCIA: A Cheat Sheet for Managing the Complicated Timing and Logistics of the Statutory IP Exchange Process,” ACI Summit on Biosimilars (June 2, 2015)

  • “PTO Proceedings Retrospect: Exploring the Growing Use of IPR, PGR and CBM Review in Hatch-Waxman Litigation,” ACI Paragraph IV Disputes Conference (April 27, 2015)

  • “Cultivating Natural Leadership Traits: Giving Women Attorneys the Communication Skills Necessary for Continued Success in the Life Sciences World,” ACI Conference on Women Leaders in EU Life Sciences Law (April 22, 2015)

  • “Timing is Everything: A Cheat Sheet for Managing the Logistics of the BPCIA Exchange Process,” ACI Summit on U.S. Biosimilars, Munich, Germany (April 21, 2015)

  • "Biobetters: Advantages and Challenges of Being Better,” Biosimilars Conference (October 22, 2014);

  • "Key IP Case Law Through the Biosimilars Lens," ACI Summit on Biosimilars (June 6, 2014)

  • "Non-Orange Book Patents in ANDA Litigation," ACI Paragraph IV Disputes Conference (April 28, 2014);

  • "NCE Exclusivity Challenges and Lessons," ACI Paragraph IV Disputes Conference (May 8, 2013)

Amicus Briefs

Scientific Articles

  • "Drosophila embryonic cell-cycle mutants," G3: Genes/Genomes/Genetics, 10:1875-1880 (2013)
  • "The E2F cell cycle regulator is required for Drosophila nurse cell DNA replication and apoptosis," Mechanisms of Development, 119:225-37 (2002)
  • "Drosophila double parked: a conserved, essential replication protein that colocalizes with the origin recognition complex and links DNA replication with mitosis and the down-regulation of S phase transcripts," Genes and Development, 14:1765-1776 (2000)
  • "ORC Localization in Drosophila follicle cells and the effects of mutations in dE2F and dDP," Genes and Development,13:827-840 (1999)
  • "S phase and differential DNA replication during Drosophila oogenesis," Genes and Cells, 3:767-776 (1998)
  • "Mutations in Drosophila DP and E2F distinguish G1-S progression from an associated transcriptional program," Genes and Development, 11:1999-2011 (1997)